Supporting Employees With ADPKD: A Resource For Payers
Creating a healthy workplace environment should be at the top of any employers list. This resource includes strategies that support employees with ADPKD. Read More
- About
- IgAN
- Events
- Resource Center
- Simulators
What interests you?+Help Us Enhance Your NephU ExperienceHelp Us Enhance Your NephU Experience
User experience form
Subtopics
Research Summary – Virtual Visits In Primary Care: Who Uses Them & Why?
As health systems begin using virtual care interfaces, understanding the patient response has been key. This article reviews one study’s effort to elucidate the patient viewpoint. Read MoreDiagnosis & Screening of Autosomal Dominant Polycystic Kidney Disease
This study was conducted to develop screening and diagnostic criteria with emphasis on divergent ADPKD mutations. Read inside to learn the results and more. Read MoreDevelopment Of The Autosomal Dominant Polycystic Kidney Disease Impact Scale: A New Health-Related Quality-Of-Life Instrument
Learn about the development of the autosomal dominant polycystic kidney disease impact scale. Read MoreBaseline Total Kidney Volume & The Rate Of Kidney Growth Are Associated With Chronic Kidney Disease Progression In Autosomal Dominant Polycystic Kidney Disease
It was found that there is a strong association between end-stage renal disease and total kidney volume. Read inside for more details and clinical implications. Read MoreUltrasound & Magnetic Resonance Imaging Shows Kidney Length Predicts Chronic Kidney Disease in ADPKD
This article reviews study findings to determine the reliability of ultrasound and kidney measurement in predicting ADPKD progression. Read MoreNephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the kidney health community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.©2025 Otsuka Pharmaceutical Development & Commercialization, Inc. All rights reserved. - IgAN
